NCT00084799View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 26, 2004

Primary Completion Date

January 25, 2006

Study Completion Date

December 20, 2006

Conditions
Lung Cancer
Interventions
BIOLOGICAL

monoclonal antibody hu3S193

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Ludwig Institute for Cancer Research

OTHER